BeStock  
Stocks › Biotechnology › AAPG

Ascentage Pharma AAPG

US equityMarket cap rank #3080Biotechnology
$11.97 −$0.47 (-3.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.97 0.00%
Open$12.26
Prev close$12.44
Day range$11.97 – $12.26
Volume5,039
Market cap$1.12B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025 · reported in CNY

RevenueCN¥574.12M-41.5% YoY
Operating profit-CN¥1.20B-223.9% YoY
Net profit-CN¥1.24B-206.4% YoY
Diluted EPS-CN¥13.96-160.4% YoY

Annual revenue

CN¥12.5MFY20CN¥27.9MFY21CN¥209.7MFY22CN¥222.0MFY23CN¥980.7MFY24CN¥574.1MFY25

Profitability & balance sheet

Gross margin93.9%
Operating margin-216.7%
Net margin-228.5%
Return on equity-240.3%
Return on assets-46.7%
Return on invested capital-59.4%
Current ratio1.22
Liabilities / assets82.5%
Cash & investmentsCN¥1.90B
Total debtCN¥2.08B
Net cash (debt)-CN¥189.36M

Where the revenue comes from

Quarter 2025/FY

By business line

  • Sales of productsCN¥499.27M 87.0%
  • Commercialization rights incomeCN¥72.63M 12.7%
  • OthersCN¥2.22M 0.4%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Balance sheet

Line item 2026 Q2
(CNY)
2025 ANNUAL
(CNY)
2025 Q4
(CNY)
2025 Q2
(CNY)
2024 ANNUAL
(CNY)
Total Assets CN¥3.24B CN¥3.96B CN¥3.96B CN¥3.05B CN¥2.62B
Total Current Assets CN¥2.29B CN¥2.94B CN¥2.94B CN¥1.91B CN¥1.47B
Cash and Cash Equivalents & Short-Term Investments CN¥1.90B CN¥2.46B CN¥2.46B CN¥1.66B CN¥1.24B
-Cash and Cash Equivalents CN¥1.90B CN¥2.46B CN¥2.46B CN¥1.66B CN¥1.24B
Receivables CN¥333.38M CN¥301.14M CN¥301.14M CN¥238.68M CN¥99.07M
-Accounts Receivable CN¥156.40M CN¥252.94M CN¥252.94M CN¥78.36M CN¥83.14M
-Other Receivables CN¥176.99M CN¥1.46M CN¥1.46M CN¥160.31M CN¥6.14M
Inventory CN¥64.30M CN¥28.62M CN¥28.62M CN¥8.59M CN¥6.60M
Total Non-Current Assets CN¥947.44M CN¥1.02B CN¥1.02B CN¥1.14B CN¥1.14B
Net PPE CN¥800.43M CN¥829.25M CN¥829.25M CN¥871.96M CN¥905.86M
-Gross PPE CN¥800.43M CN¥1.12B CN¥1.12B CN¥871.96M CN¥1.13B
Investments and Advances CN¥40.01M CN¥37.03M CN¥37.03M CN¥37.34M CN¥33.86M
-Long Term Equity Investment CN¥33.01M CN¥33.03M CN¥33.03M CN¥32.72M CN¥32.72M
Goodwill and Other Intangible Assets CN¥62.26M CN¥90.63M CN¥90.63M CN¥95.69M CN¥100.69M
-Goodwill CN¥24.69M CN¥24.69M CN¥24.69M CN¥24.69M CN¥24.69M
-Other Intangible Assets CN¥37.57M CN¥65.94M CN¥65.94M CN¥70.99M CN¥76.00M
Non-Current Deferred Assets CN¥18.38M CN¥61.81M CN¥61.81M CN¥33.39M CN¥74.77M
Other Non-Current Assets CN¥26.36M – – CN¥99.06M –
Total Liabilities CN¥2.67B CN¥2.63B CN¥2.63B CN¥2.37B CN¥2.34B
Total Current Liabilities CN¥1.88B CN¥1.64B CN¥1.64B CN¥1.24B CN¥1.17B
Payables CN¥338.84M CN¥234.58M CN¥234.58M CN¥368.03M CN¥251.61M
-Accounts Payable CN¥106.91M CN¥106.74M CN¥106.74M CN¥118.68M CN¥91.97M
-Other Payable CN¥231.93M CN¥114.14M CN¥114.14M CN¥249.36M CN¥150.02M
Short-Term Debt and Capital Lease Obligation CN¥1.48B CN¥1.22B CN¥1.22B CN¥833.78M CN¥779.06M
-Current Debt CN¥1.47B CN¥1.22B CN¥1.22B CN¥833.78M CN¥769.62M
-Current Capital Lease Obligation CN¥9.62M CN¥7.28M CN¥7.28M – CN¥9.44M
Current Deferred Liabilities CN¥69.54M CN¥60.09M CN¥60.09M CN¥37.49M CN¥54.09M
Total Non-Current Liabilities CN¥791.36M CN¥985.99M CN¥985.99M CN¥1.13B CN¥1.18B
Long Term Debt and Capital Lease Obligation CN¥619.45M CN¥757.24M CN¥757.24M CN¥882.38M CN¥889.44M
-Long Term Debt CN¥605.34M CN¥742.33M CN¥742.33M CN¥882.38M CN¥868.64M
-Long Term Capital Lease Obligation CN¥14.11M CN¥14.91M CN¥14.91M – CN¥20.79M
Non-Current Deferred Liabilities CN¥164.75M CN¥216.72M CN¥216.72M CN¥236.13M CN¥281.33M
Other Non-Current Liabilities CN¥7.16M CN¥12.03M CN¥12.03M CN¥12.42M CN¥6.27M
Total Equity CN¥565.83M CN¥1.33B CN¥1.33B CN¥675.91M CN¥274.16M
Stockholders' Equity CN¥556.39M CN¥1.32B CN¥1.32B CN¥666.00M CN¥264.19M
Capital Stock CN¥256,000.00 CN¥256,000.00 CN¥256,000.00 CN¥239,000.00 CN¥214,000.00
-Common Stock CN¥256,000.00 CN¥256,000.00 CN¥256,000.00 CN¥239,000.00 CN¥214,000.00
Additional Paid-In Capital CN¥8.93B CN¥8.92B CN¥8.92B CN¥7.55B CN¥6.55B
Retained Earnings -CN¥7.83B -CN¥7.01B -CN¥7.01B -CN¥6.36B -CN¥5.77B
Less: Treasury Stock -CN¥16.36M -CN¥2.96M -CN¥2.96M -CN¥2.96M -CN¥8,000.00
Gains/Losses Not Affecting Retained Earnings -CN¥524.19M -CN¥576.36M -CN¥576.36M -CN¥516.07M -CN¥510.59M
Minority Interests CN¥9.45M CN¥9.75M CN¥9.75M CN¥9.91M CN¥9.97M
-Taxes Receivable – CN¥46.75M CN¥46.75M – CN¥9.79M
Prepaid Assets – CN¥144.33M CN¥144.33M – CN¥107.28M
Restricted Cash – CN¥5.69M CN¥5.69M – CN¥24.63M
-Accumulated Depreciation – -CN¥287.03M -CN¥287.03M – -CN¥221.44M
Non-Current Prepaid Assets – CN¥690,000.00 CN¥690,000.00 – CN¥2.44M
-Total Tax Payable – CN¥13.70M CN¥13.70M – CN¥9.63M
Current Accrued Expenses – CN¥124.25M CN¥124.25M – CN¥81.86M
Other Current Liabilities – CN¥1.97M CN¥1.97M – –
Non Current Accounts Receivables – – – – CN¥26.03M

Income statement

Line item 2025 ANNUAL
(CNY)
2024 ANNUAL
(CNY)
2023 ANNUAL
(CNY)
2022 ANNUAL
(CNY)
2021 ANNUAL
(CNY)
Total Revenue as Reported CN¥574.12M CN¥980.65M CN¥221.98M CN¥209.71M CN¥27.91M
Total Operating Revenue CN¥574.12M CN¥980.65M CN¥221.98M CN¥209.71M CN¥27.91M
Cost of Revenue CN¥48.94M CN¥29.09M CN¥30.54M CN¥22.00M CN¥3.33M
Gross Profit CN¥525.18M CN¥951.57M CN¥191.44M CN¥187.71M CN¥24.58M
Operating Expense CN¥1.72B CN¥1.32B CN¥1.06B CN¥1.04B CN¥894.42M
Selling and Admin Expenses CN¥599.92M CN¥383.12M CN¥376.46M CN¥328.02M CN¥191.26M
-Selling & Marketing Expense CN¥353.64M CN¥196.00M CN¥195.39M CN¥157.42M CN¥47.75M
-General & Admin Expense CN¥246.28M CN¥187.13M CN¥181.08M CN¥170.60M CN¥143.51M
Research & Development CN¥1.14B CN¥947.25M CN¥706.97M CN¥743.10M CN¥766.49M
Other Operating Expenses -CN¥14.50M -CN¥9.07M -CN¥19.36M -CN¥33.60M -CN¥63.34M
Operating Profit -CN¥1.20B -CN¥369.73M -CN¥872.64M -CN¥849.81M -CN¥869.84M
Net Non-Operating Interest Income (Expense) CN¥28.06M -CN¥26.62M -CN¥63.65M -CN¥43.06M -CN¥9.63M
Non-Operating Interest Income CN¥82.13M CN¥37.84M CN¥32.41M CN¥9.73M CN¥7.11M
Non-Operating Interest Expense CN¥54.07M CN¥64.46M CN¥96.06M CN¥52.79M CN¥16.73M
Other Income (Expense) -CN¥66.41M CN¥1.09M CN¥3.42M CN¥5.70M CN¥47.21M
Gain on Sale of Security -CN¥11.30M CN¥5.86M CN¥3.74M CN¥6.97M CN¥70.62M
Earnings from Equity Interest CN¥314,000.00 -CN¥281,000.00 CN¥1.08M -CN¥278,000.00 CN¥0.00
Special Income (Charges) -CN¥18,000.00 -CN¥50,000.00 CN¥4,000.00 CN¥2.07M -CN¥34,000.00
-Gain on Sale of Property/Plant/Equipment -CN¥18,000.00 -CN¥50,000.00 CN¥4,000.00 CN¥2.07M -CN¥34,000.00
Other Non-Operating Income (Expenses) -CN¥55.41M -CN¥4.44M -CN¥1.40M -CN¥3.06M -CN¥23.38M
Pretax Profit -CN¥1.24B -CN¥395.26M -CN¥932.86M -CN¥887.17M -CN¥832.25M
Tax CN¥6.94M CN¥10.43M -CN¥7.15M -CN¥4.25M -CN¥49.83M
Net Profit -CN¥1.24B -CN¥405.68M -CN¥925.71M -CN¥882.92M -CN¥782.42M
Profit from Continuing Operations -CN¥1.24B -CN¥405.68M -CN¥925.71M -CN¥882.92M -CN¥782.42M
Minority Interests -CN¥218,000.00 -CN¥247,000.00 -CN¥75,000.00 CN¥0.00 –
Net Income to Parent Company -CN¥1.24B -CN¥405.43M -CN¥925.64M -CN¥882.92M -CN¥782.42M
Net Income to Common Stockholders -CN¥1.24B -CN¥405.43M -CN¥925.64M -CN¥882.92M -CN¥782.42M
Basic EPS -CN¥13.96 -CN¥5.36 -CN¥13.12 -CN¥13.40 -CN¥12.28
Diluted EPS -CN¥13.96 -CN¥5.36 -CN¥13.12 -CN¥13.40 -CN¥12.28

Cash flow

Line item 2025 ANNUAL
(CNY)
2024 ANNUAL
(CNY)
2023 ANNUAL
(CNY)
2022 ANNUAL
(CNY)
2021 ANNUAL
(CNY)
Operating Cash Flow -CN¥1.17B -CN¥111.36M -CN¥726.08M -CN¥653.92M -CN¥604.68M
Net cash flow from continuing operations -CN¥1.17B -CN¥111.36M -CN¥726.08M -CN¥653.92M -CN¥604.68M
Net Income from Continuing Operations -CN¥1.24B -CN¥395.26M -CN¥932.86M -CN¥887.17M -CN¥832.25M
Gain/Loss from Continuing Operations CN¥9.87M -CN¥6.36M -CN¥5.52M -CN¥18.52M -CN¥95.04M
Depreciation & Depletion & Amortization CN¥86.48M CN¥93.17M CN¥93.20M CN¥62.92M CN¥28.33M
Other Non-Cash Items CN¥82.92M CN¥64.37M CN¥96.06M CN¥52.58M CN¥34.65M
Change in Working Capital -CN¥143.50M CN¥110.97M -CN¥9.15M CN¥104.41M CN¥189.65M
-Change in Receivables -CN¥169.80M CN¥62.75M -CN¥91.54M -CN¥388,000.00 -CN¥53.97M
-Change in Inventory -CN¥26.20M CN¥9.57M -CN¥6.72M -CN¥5.52M -CN¥3.93M
-Change in Prepaid Assets -CN¥86.34M -CN¥14.42M -CN¥7.84M CN¥3.12M -CN¥17.68M
-Change in Payables and Accrued Expense CN¥128.58M CN¥98.03M CN¥25.46M CN¥82.15M CN¥65.37M
-Change in Other Current Assets CN¥27.78M -CN¥48.95M -CN¥3.55M CN¥29.38M CN¥15.04M
-Change In Other Working Capital -CN¥17.54M CN¥3.99M CN¥75.04M -CN¥4.32M CN¥194.87M
Net cash flow from investing -CN¥1.00B -CN¥362.04M CN¥21.92M -CN¥384.61M -CN¥466.52M
Net Cash Flow from Continuing Investing Activities -CN¥1.00B -CN¥362.04M CN¥21.92M -CN¥384.61M -CN¥466.52M
Net PPE Purchase and Sale -CN¥27.57M -CN¥24.29M -CN¥46.09M -CN¥200.94M -CN¥435.08M
Net Intangibles Purchase and Sale CN¥0.00 CN¥0.00 -CN¥10.74M -CN¥33.68M -CN¥1.21M
Net Business Purchase and Sale -CN¥43.34M -CN¥25.52M -CN¥20.00M -CN¥20.00M -CN¥36.20M
Net Investment Purchase and Sale -CN¥929.14M -CN¥312.23M CN¥98.75M -CN¥130.00M CN¥5.97M
Financing Cash Flow CN¥2.54B CN¥314.77M CN¥368.75M CN¥619.27M CN¥1.78B
Net Cash Flow from Continuing Financing Activities CN¥2.54B CN¥314.77M CN¥368.75M CN¥619.27M CN¥1.78B
Net Issuance Payments Of Debt CN¥307.26M -CN¥145.34M -CN¥13.36M CN¥695.87M CN¥539.50M
Net Common Stock Issuance CN¥2.30B CN¥533.94M CN¥464.16M -CN¥26.78M CN¥1.17B
Cash Dividends Paid CN¥0.00 CN¥0.00 CN¥0.00 CN¥0.00 CN¥0.00
Proceeds from Stock Option Exercised CN¥4,000.00 CN¥6,000.00 CN¥8,000.00 CN¥19,000.00 CN¥103.87M
Net Other Financing Charges -CN¥11.73M -CN¥13.28M CN¥10.29M – -CN¥16.07M
Ending Cash Balance CN¥1.20B CN¥893.10M CN¥1.04B CN¥1.35B CN¥1.71B
Net Change in Cash CN¥365.92M -CN¥158.63M -CN¥335.40M -CN¥419.26M CN¥710.19M
Beginning Cash Balance CN¥893.10M CN¥1.04B CN¥1.35B CN¥1.71B CN¥1.02B
Effect of Exchange Rate Changes -CN¥63.24M CN¥13.68M CN¥27.81M CN¥58.01M -CN¥23.28M
Free Cash Flow -CN¥1.20B -CN¥135.65M -CN¥782.92M -CN¥890.88M -CN¥1.04B
-Change in Other Current Liabilities – – – – -CN¥10.06M

Discussion

No comments yet — be the first to weigh in on AAPG.

Sign in to join the discussion.

Scroll to Top